Podcasts about Clostridium difficile

health doctors fitness wellness functional medicine clinical trials voiceamerica c diff clostridium difficile c difficile

Play Episode Listen Later May 4, 2023 60:00

Clostridioides difficile, a.k.a. C. diff is a horrible infection.500,000 people a year get it from simply using antibiotics or from coming in contact with contaminated clothing or surfaces in bathrooms. IT KILLS 28,000 PEOPLE A YEAR FROM UNCONTROLLABLE DIARRHEA. One in 11 people get it from using antibiotics.I in six people get recurrent bouts of it. 80 people a day die. Doctor's Biome Colon Health Medical Food, a delicious special probiotic drink has been proven in independent laboratory tests as well using it in patients to COMPLETELY SUPPRESS C. diff! We will discuss how C. diff. effects your body, how to prevent it if possible and how to get into the FREE Open Clinical Trial that will be starting soon to help in the dietary management of it. This is a must listen to show for anyone who has it.

Free Open Clinical Trial for C. difficile!

health doctors fitness wellness functional medicine clinical trials voiceamerica c diff clostridium difficile c difficile

Play Episode Listen Later May 4, 2023 60:00

Clostridioides difficile, a.k.a. C. diff is a horrible infection.500,000 people a year get it from simply using antibiotics or from coming in contact with contaminated clothing or surfaces in bathrooms. IT KILLS 28,000 PEOPLE A YEAR FROM UNCONTROLLABLE DIARRHEA. One in 11 people get it from using antibiotics.I in six people get recurrent bouts of it. 80 people a day die. Doctor's Biome Colon Health Medical Food, a delicious special probiotic drink has been proven in independent laboratory tests as well using it in patients to COMPLETELY SUPPRESS C. diff! We will discuss how C. diff. effects your body, how to prevent it if possible and how to get into the FREE Open Clinical Trial that will be starting soon to help in the dietary management of it. This is a must listen to show for anyone who has it.

Free Open Clinical Trial for C. difficile!

health doctors fitness wellness functional medicine clinical trials voiceamerica c diff clostridium difficile c difficile

Play Episode Listen Later May 4, 2023 60:00

Clostridioides difficile, a.k.a. C. diff is a horrible infection.500,000 people a year get it from simply using antibiotics or from coming in contact with contaminated clothing or surfaces in bathrooms. IT KILLS 28,000 PEOPLE A YEAR FROM UNCONTROLLABLE DIARRHEA. One in 11 people get it from using antibiotics.I in six people get recurrent bouts of it. 80 people a day die. Doctor's Biome Colon Health Medical Food, a delicious special probiotic drink has been proven in independent laboratory tests as well using it in patients to COMPLETELY SUPPRESS C. diff! We will discuss how C. diff. effects your body, how to prevent it if possible and how to get into the FREE Open Clinical Trial that will be starting soon to help in the dietary management of it. This is a must listen to show for anyone who has it.

Nootropics Rabbit Hole: How Gut Bacteria Cuts Off Dopamine

Holistic Nootropics

Play Episode Listen Later Apr 17, 2023 18:37

Join Erik down the Nootropics Rabbit Hole to discover the connection between the gut bacteria Clostridium Difficile's (C.Diff)'s connection to mental health. Never underestimate the gut/brain connection. Megasporebiotic (probiotic) can be purchased here: Buy Megasporebiotic Masszymes Digestive Enzymes can be purchased here: Buy Masszymes Download the Free Supplement Buying Guide Follow Us On Socials! Tik Tok Instagram YouTube

cuts gut health rabbit hole dopamine diff probiotics nootropics gut bacteria clostridium difficile

Raising Awareness About Causes and Dangers of Clostridium Difficile with Christian Lillis Peggy Lillis Foundation TRANSCRIPT

americans executive director foundation dangers raising awareness clostridium clostridium difficile

Play Episode Listen Later Nov 18, 2022

Christian Lillis, the Executive Director of the Peggy Lillis Foundation -PLF - is on a mission to raise awareness about the highly contagious disease Clostridium difficile and to get C. diff recognized as a nationally notifiable disease. The Foundation also provides a nutrition and lifestyle guide to give patients the ability to know what to eat to prevent recurrence and help prevent C. diff and other infections. Chris explains, "We've had some polls done that show about a third of Americans have heard of C. diff. They've heard the term. That doesn't necessarily mean that they understand it. Just because we hear a lot of things doesn't mean we have great knowledge about them. So, I'll address just a little bit about the disease itself, so people have a sense of it. C. diff is the most common cause of infectious diarrhea in healthcare settings. There are about half a million infections every year, and at this point, there are about 25 to 30,000 deaths each year. And something that I find remarkable is that in 2011, C. diff was considered the 17th leading cause of death for people 65 years and older. So, it has a huge impact, causing a lot of harm, a lot of death." "The guide contains a wealth of information about foods that you can probably tolerate during an acute infection, as well as the foods that promote a healthy gut microbiome. That includes a lot of probiotic-rich foods, fiber-rich foods, and prebiotic-rich foods. And then something that we're particularly excited about is that the guide contains 30 recipes that are grouped into what is most likely to be tolerated and what foods will help restore the microbiome. And all of those recipes were developed or adapted by people who have battled C. diff based on what they found most helpful." #PeggyFoundation #Cdiff #ClostridiumDifficile #Microbiome #PatientAdvocacy #CdiffAwarenessMonth peggyfoundation.org Listen to the podcast here

Raising Awareness About Causes and Dangers of Clostridium Difficile with Christian Lillis Peggy Lillis Foundation

americans executive director foundation dangers raising awareness clostridium clostridium difficile

Play Episode Listen Later Nov 18, 2022 17:46

Christian Lillis is the Executive Director of the Peggy Lillis Foundation -PLF - is on a mission to raise awareness about the highly contagious disease Clostridium difficile and to get C. diff recognized as a nationally notifiable disease. The Foundation is also providing a nutrition and lifestyle guide to give patients the ability to know what to eat to prevent recurrence and help prevent C. diff and other infections. Chris explains, "We've had some polls done that show about a third of Americans have heard of C. diff. They've heard the term. That doesn't necessarily mean that they understand it. Just because we hear a lot of things doesn't mean we have great knowledge about them. So, I'll address just a little bit about the disease itself, so people have a sense of it. C. diff is the most common cause of infectious diarrhea in healthcare settings. There are about half a million infections every year, and at this point, there are about 25 to 30,000 deaths each year. And something that I find remarkable is that in 2011, C. diff was considered the 17th leading cause of death for people 65 years and older. So, it has a huge impact, causing a lot of harm, a lot of death." "The guide contains a wealth of information about foods that you can probably tolerate during an acute infection, as well as the foods that promote a healthy gut microbiome. That includes a lot of probiotic-rich foods, fiber-rich foods, and prebiotic-rich foods. And then something that we're particularly excited about is that the guide contains 30 recipes that are grouped into what is most likely to be tolerated and what foods will help restore the microbiome. And all of those recipes were developed or adapted by people who have battled C. diff based on what they found most helpful." #PeggyFoundation #Cdiff #ClostridiumDifficile #Microbiome #PatientAdvocacy #CdiffAwarenessMonth peggyfoundation.org Download the transcript here

7 Causes of Diarrhea after bariatric surgery

The Gastric Health Show

Play Episode Listen Later Oct 3, 2022 39:07

Diarrhea after bariatric surgery Dawn: (00:00) Hello, and welcome to the gastric health show. My name is Dawn Boxell and we are here this week and we are going to discuss the seven causes of diarrhea after bariatric surgery. Now, I know no one likes to discuss this embarrassing topic. But if you have this[Read More] The post 7 Causes of Diarrhea after bariatric surgery appeared first on Gastric Health.

gas bam diarrhea sibo bloating pei fodmap bariatric surgery fodmaps abdominal pain small intestinal bacterial overgrowth clostridium difficile cholecystectomy chronic diarrhea

The Microbiome: Trust Your Gut?

The Naked Scientists Podcast

Play Episode Listen Later Sep 6, 2022 35:45

When it comes to treating diseases, we often think of lifestyle changes, pills and procedures. What often isn't considered is poo. But this week, the NICE guidelines - which recommend treatments for use in the NHS - were updated so people who have a recurring gut infection caused by the Clostridium difficile superbug are eligible to receive a transplant of healthy stool in a procedure called fecal microbiota transplantation (FMT) - sometimes dubbed a "transpoosion" - to aid their recovery. This procedure alters the balance of bacteria living in the gut, helping to hold the bad bugs in check... Like this podcast? Please help us by supporting the Naked Scientists

anxiety depression nhs ibs microbiome ibd trust your gut ecoli gut bacteria clostridium fmt gut microbes human microbiome naked scientists clostridium difficile andrew page

Episode 238 - How Diet Fixes More Than You Could Possibly Imagine And Vice-versa

Topical Talkology

Play Episode Listen Later Aug 19, 2022 30:38

Gut Immune Body Brain Axis.Dr Gundry:Leaky Gut, gut microbiome and dietRenowned Cardiovascular Surgeon who realised that all he was doing was treating thesymptoms so he studied the underlying causes.The lining of the gut is one cell thickAs bacteria break down the gut that is when ageing startsIbuprofen or roundup disastrous the bacteria populationSkin is a mirror of the lining of the gutJoints do not naturally wear out.Animal model C Elegans as bacteria begin to break down the wall of the gut that is whenageing starts105 year old people have a diverse set of bugs identical to a healthy 30 year old. It is notattacking the wall of the gut.Ecermansia musinophilia. Lives in the mucous layer whose job is to trap lectins plantproteins looking for sugar molecules and to protect the wall of the gut from harmful bacteria.Ecermansia musinophilia eats mucus which in turn makes more mucus.Metformin works by increasing mucous and this change in bacteria makes some peoplehave mild diarrhoea as the bacteria change.If we damage this lining eg ibuprofen or food with roundup destroys the bacteria populationand gut lining.Glyocosade an antibacterial damages Ecermansia Musinophilia even though it does notdirectly affect human cells.Antibiotics in food or direct prescription eg ladies who take low dose for UTI have a higherincidence of heart disease.Heart disease is an autoimmune disease starting in the gut.Cholesterol is an innocent bystander which gets sucked into the inflamed wall of a bloodvessel.Infants with heart transplants have coronary artery disease with pathology identical withtypical coronary artery disease.Lectins which are a foreign protein which can stick to sugar molecules on the surface ofblood vessels are the cause of atherosclerosis and removing lectins reduces those markers.Lectins are one of the plant defence systems. Sticky proteins that look for specific sugarmolecules to stick to which insights an inflammtory response.Joints do not normally wear out. Usually you can find bacterial particles in the joint fluid ofarthritisBecauseLectins broke down the wall of the gut. 65% of the immune system is behind the wall of thegut because the gut is where the outside word gets through. A reason why we store fat inthe gut is to provide energy to the immune system. Similarly fat on the outside ofatherosclerotcic blood vessles correlates with the severity of inflammation.Fat is not the cause . It is there because of the inflammation and the inflammation is theredue to the leaky gut.The immune system responds to antigens on bacteria of viruses. Lectins have antigens withcross reactivity with other proteins in the body. Eg thyroid.Nightshade vegetables or peanutsLectins disrupt the microbiome and break up the lining of the gut allowing entry by lectinsand by bacteria or bacterial particles.Hence if you inject a bacterial lipopolysaccharide into a person you can induce septic shock.Alzheimers Parkinsons is neuroinflammation.Most amyloid is produced by bacteria in the gut. Therefore 40 billion dollars invested inantiamyloid drugs has been a waste because amyloid is produced by the amyloid producingbacteria inthe gut fet by western diet. Then the amyloid has to get through the wall of the gut.Once they get through the gut wall and goto the brain it will produce more amyloid.Cholesterol and amyloid coexist in dementia in those with the apoE gene.The apo E gene codes for a carrier molecule because it is less efficient at transportingcholesterol. It cannot get out of the cell after it has been attracted by inflammation.Faecal microbial transplant:1970s broad spectrum antibiotics came out which made it much quicker to treat infectionsbut it also wiped out the gut bacteria. Normally 10000 species of bacteria.Pseudomembranous colitis was caused by Clostridium Difficile over growing. Initial studydone from the faeces of medical students.Faecal enemas treated the pseudomembranous colitis.Meat with animals treated by antibiotics can also cause problems.60% of faeces is bacteriaOral microbiome and cloud of bacteria around us –Holobiome . This defines our personalspace.Kissing is a human and ape characteristic. Exchanging oral microbiome. Bacteria decidewhether the other person's bacteria are compatible with them.Women have a gut feeling because they are more capable of listening to their microbiome. We inherit our microbiome from our mother. All of the mitochondria are involved with bacteriainherited from our mother. Bacteria communicate to their ‘sisters 'ie the body's mitochondria.Autism: kids have a different microbiome than ‘normal'The placental microbiome is important in educating the foetal immune system.Oral faecal transplants for 6 weeks in autistic kids. Almost immediately 50% autismsymptoms reduced.Ecermansia like tubers, mushrooms, -study in Asia find 90% reduction in Alzheimers withtwo cups of mushrooms a week.Inulin containing compounds eg chicory, radicchio, jerusalem artichoke.Exercise women who exercise routinely from midlife have a 90% reduction in Alzheimers. Inthose who get AD it happens 11 years later. Housework can be important part of exercise.Meditation and yoga also changes the gut microbiome.Lymph system in the brain in deep sleep -early in the sleep cycle-shrinks by 20% and thesebad proteins are squeezed out. You need a 3-4 hour window between sleep and dinnerbecause blood flow diverts to the gut.Olive oil /walnuts / mediterranean low fat diet: first two groups improved memory after 5years. 3rd group lost memoryThose with CVD had a 30% reduction in events, the low fat group continued CVS events.Polyphenos in olive oil grow proteinsTMAO is made by gut bacteria primarily from animal protein especially choline eg egg yolkand carnitine . TMAO damages blood vessels. Polyphenols in certain olive oil and red winebalsamic vinegar that paralyse enzyme systems in the bacteria so they do not make TMAO.However the logical error here is that eggs which are high in choline are not associated withincreased morbidity.Vitamin D at least 5000 units a day . Almost all cancer patietns and autoimmune pateitnshave low vitamin D. HIgher your VItamin D the longer your telomere. Stem cells in the gutare simulated by vitamin D.VItamin CLectins are present in most plant foods but especially high in:legumes, such as beans, lentils, peas, soybeans, and peanutsnightshade vegetables, such as tomatoes and eggplantdairy products, including milkgrains, such as barley, quinoa, and riceThe Roll of Inflammation in Depression and FatigueFrontiers In Immunology:CH Lee 2019:Immune system link to depression first noticed with immunotherapy eg INFa (which activates an inflammatory antiviral response) for Hepatitis C : associated with raised proinflammatory cytokines and depression and fatigue.20% of patients treated with INFa developed depression which resolved on discontinuationbut also increased the risk of depression in future.Also people with higher IL6 aged 9 were more likely to have depression aged 18 in a dosedependent manner.Innate immune system seems to be lower in depression eg NK cells and also less antiinflammatory regulatory T cells whereas inflammatory monocytes are activated.There is commonality in immune activation from autoimmune disorder such as multiplesclerosis or immune reactions in sepsis.Antidepressants reduce inflammation while a higher baseline level of inflammation predicts apoorer treatment response.People with depression have been shown to have higher inflammatory markers which canbe used to predict treatment efficacy and future recurrences of depression.Elevated inflammatory markets eg TNFa after an MI disrupt the blood brain barrier causingdepression.Inflammatory changes in the brain with raised TNFa in the hippocampus and striatumprecede development of depressive symptoms.Neurogenesis is inhibited by the kynurenine pathway which is rescued by both inhibitors ofthis pathway and traditional antidepressants.TNFa also increases glutamate release causing exocytotic damage to surroundingsneurones.Conditions associated with chronic immune activation such as asthma, atopy, diabetes mMS, RhA, SLE are all associated with raised levels of depression eg 36% of asthma havedepression who also had higher TNFa than those who were not depressed. 75% in RhAMS up to 50% risk of depression.Acute inflammation with sepsis also causes depression and raises the risk of depression infuture which in animal models can be reduced by using steroid during the acute sepsis.Antidepressants reduce inflammatory markers perhaps SNRI more effective than SSRI andalso ECT adds in return to normal of NK activity.Directly reducing the immune response eg anti TNF a or Caspase Inhibitors have beenshown to reduce depression. Rituximab which is an antibody that targets and depletes Bcells in the treatment of RhA also reduces depression.Aspirin can reduce depression but can also reduce the effect of an SSRI.

#168 - Precisamos falar sobre diarreias neonatais e Clostridium difficile - Dr. Rodrigo Otávio Silva

SuinoCast

Play Episode Listen Later Jun 2, 2022 39:10

Aquele assunto que nunca sai de moda, sabe? Diarreia na maternidade sempre é motivo de pesadelos para o produtor, colaborador, veterinário, enfim, para toda a produção. Por isso, convidamos o Professor Rodrigo Otávio para bater um papo sobre "as últimas sobre diarreia neonatal", com foco em

tamb teste lugares aquele vacina evolu preven atualiza falou precisamos falar sobre confesso ceva schippers clostridium difficile

Correcting Imbalance in the Gut Microbiome to Treat Clostridium Difficile Infections with Dr. Tom Lendvay Tend TRANSCRIPT

treat fda cap clinical infection tend chief medical officers correcting gut microbiome imbalance clostridium clostridium difficile

Play Episode Listen Later May 17, 2022

Dr. Tom Lendvay is the Chief Medical Officer of Tend, which addresses the gut microbiome of the severe intestinal infection Clostridium difficile CDIF. Currently, recurrent Clostridium difficile is the only FDA-regulated disease for the use of microbiome transplants outside of a clinical trial. Clinical trials are also underway applying microbiome transplants to intestinal diseases such as inflammatory bowel diseases, irritable bowel syndrome, and other diseases outside of the gut. Tom explains, "Tend is focused on two types of offerings. One is a device called the CAP device, a collection processing device that allows a clinician or a researcher to collect a sample and process it, mix it, filter it and encapsulate it into orally ingestible capsules that can be stored in a freezer." "The other side is the data side, which is understanding. So, doing microbiome analyses on the donors, on the recipient ill patients and seeing how their microbiome changes over time and learning who's the best donor for the best recipient. Those two offerings do not exist today, and right now, the process for a clinician, for a researcher to provide microbiome transplants to their patients is extremely onerous and laborious." @Tend_Health #FMT #CDIF #Microbiome #GutMicrobiome #MedicalDevice #Healthcare #Patient tend-health.com Listen to the podcast here

Correcting Imbalance in the Gut Microbiome to Treat Clostridium Difficile Infections with Dr. Tom Lendvay Tend

treat fda cap clinical infection tend chief medical officers correcting gut microbiome imbalance clostridium clostridium difficile

Play Episode Listen Later May 17, 2022 20:57

Dr. Tom Lendvay is the Chief Medical Officer of Tend, which addresses the gut microbiome of the severe intestinal infection Clostridium difficile CDIF. Currently, recurrent Clostridium difficile is the only FDA-regulated disease for the use of microbiome transplants outside of a clinical trial. Clinical trials are also underway applying microbiome transplants to intestinal diseases such as inflammatory bowel diseases, irritable bowel syndrome, and even other diseases outside of the gut. Tom explains, "Tend is focused on two types of offerings. One is a device called the CAP device, a collection processing device that allows a clinician or a researcher to collect a sample and process it, mix it, filter it and encapsulate it into orally ingestible capsules that can be stored in a freezer." "The other side is the data side, which is understanding. So, doing microbiome analyses on the donors, on the recipient ill patients and seeing how their microbiome changes over time and learning who's the best donor for the best recipient. Those two offerings do not exist today, and right now, the process for a clinician, for a researcher to provide microbiome transplants to their patients is extremely onerous and laborious." @Tend_Health #FMT #CDIF #Microbiome #GutMicrobiome #MedicalDevice #Healthcare #Patient tend-health.com Download the transcript here

Clostridium Difficile Treatment: Focus on the New Guidelines

USF Health’s IDPodcasts

Play Episode Listen Later Jan 18, 2022 40:07

Dr. Mercurio, an ID Clinical Pharmacy Specialist at the James A Haley Veterans Hospital, presents an update on Clostridium Difficile infection (CDI). Dr. Mercurio begins by sharing a timeline of the history of C difficile treatment. She then reviews the epidemiology of this common hospital pathogen. Next, she discusses the clinical definition of CDI. Dr. Mercurio next relates changes to the c difficile recommendations in the 2017 and 2021 guidelines. Finally, she discusses later generation treatments including Fidaxomicin and Bezlotoxumab. From a presentation recorded in August 2021.

treatments cdi mercurio new guidelines clostridium difficile

Infectious Disease | Clostridium difficile (C. diff)

The Medbullets Step 2 & 3 Podcast

Play Episode Listen Later Dec 4, 2021 14:24

In this episode, we review the high-yield topic of Clostridium difficile (C. diff) from the Infectious Disease section. Follow Medbullets on social media: Facebook: www.facebook.com/medbullets Instagram: www.instagram.com/medbulletsofficial Twitter: www.twitter.com/medbullets

infectious diseases clostridium c diff clostridium difficile

Encore: C. DIFF ( Clostridium difficile) is there a Cure?

united states health fitness wellness natural cure functional medicine microbiome probiotics ozone voiceamerica clostridium ozone therapy c diff clostridium difficile

Play Episode Listen Later Oct 21, 2021 60:00

Clostridium difficile A.K.A. C DIFF , is an intestinal infection caused by TAKING antibiotics for other infections, eating foods containing antibiotics or transmission by contact with the bacteria in contaminated settings such as hospitals.500,000 people in the USA get it every year (hundreds of thousands more worldwide) and 30,000 people, mostly seniors and children die each year from the complications of the uncontrolled diarrhea that it causes. We will discuss the latest NATURAL ways to treat it to successfully eliminate, permanently, completely once and for all!

Encore: C. DIFF ( Clostridium difficile) is there a Cure?

united states health fitness wellness natural cure functional medicine microbiome probiotics ozone voiceamerica clostridium ozone therapy c diff clostridium difficile

Play Episode Listen Later Oct 21, 2021 60:00

Clostridium difficile A.K.A. C DIFF , is an intestinal infection caused by TAKING antibiotics for other infections, eating foods containing antibiotics or transmission by contact with the bacteria in contaminated settings such as hospitals.500,000 people in the USA get it every year (hundreds of thousands more worldwide) and 30,000 people, mostly seniors and children die each year from the complications of the uncontrolled diarrhea that it causes. We will discuss the latest NATURAL ways to treat it to successfully eliminate, permanently, completely once and for all!

Clostridium Difficile: History, Management, and Updates

USF Health’s IDPodcasts

Play Episode Listen Later Jul 19, 2021 39:00

Dr. Contreras, Infectious Diseases fellow at the University of South Florida, discusses a review of Clostridium difficile disease, a major healthcare-associated disorder. He begins by discussing the history of this potentially devastating disease. He then reviews basic epidemiology trends over the last several decades. Next, he reviews C. difficile risk factors. Following this, Dr. Contreras shares the latest recommendations from the recently published new C. difficile IDSA guidelines, including recent changes to the initial treatment of first outbreaks of the disease. Lastly, Dr. Contreras discusses management options for recurrent C difficile, including fecal transplantation, Bezlotoximab, and other potential future therapies.

university history management south florida infectious diseases contreras clostridium idsa clostridium difficile

Combating Clostridium Difficile in IBD Patients

GI Insights

Play Episode Listen Later May 24, 2021

Host: Neilanjan Nandi, MD Guest: Jessica Allegretti, MD, MPH Also known as C. diff for short, Clostridium difficile is an extremely difficult intestinal disease to manage…but not an impossible one. Joining Dr. Neil Nandi to share her insights on how to best mange C. diff in IBD patients is Dr. Jessica Allegretti, the Associate Director of the Crohn's and Colitis Center and the Director of the Fecal Microbiota Transplant Program at the Brigham and Women's Hospital in Boston, Massachusetts.

women director hospitals patients massachusetts md associate director combating crohn infectious diseases brigham ibd rmd clostridium clostridium difficile reachmd general medicine and primary care gastroenterology and hepatology hiv/aids and infectious disease gi insights

Insights on an IV Antitoxin Infusion for Clostridium Difficile

GI Insights

Play Episode Listen Later May 24, 2021

Host: Neilanjan Nandi, MD Guest: Jessica Allegretti, MD, MPH Bezlotoxumab is an IV antitoxin infusion treatment option for Clostridium difficile (C. diff) that's been shown to reduce recurrence in IBD patients…so why isn't it being used as much as it should be? Here to share the latest data and insights on bezlotoxumab as a treatment option for IBD patients with C. diff is Dr. Jessica Allegretti, Associate Director of the Crohn's and Colitis Center and Director of the Fecal Microbiota Transplant Program at the Brigham and Women's Hospital in Boston, Massachusetts.

women director hospitals massachusetts md iv associate director crohn infectious diseases brigham ibd infusion rmd clostridium clostridium difficile reachmd general medicine and primary care gastroenterology and hepatology hiv/aids and infectious disease gi insights

41// Do you have anxiety, depression, or ADHD? Here's one reason to check your gut.

THE BETTER BELLY PODCAST - Gut Health Transformation Strategies for a Better Belly, Brain, and Body

Play Episode Listen Later May 13, 2021 23:06

Do you struggle with anxiety, depression, or difficulty focusing?Have you been diagnosed with ADD or ADHD?Do you experience feelings of sadness for seemingly no reason?Are you gaining weight, or not losing it, despite working out and eating healthy?If you are, you may be being impacted by a specific pathogen in the gut called Clostridium Difficile, or for short, C. Diff. This bacterium can impact your neurotransmitter balance and impact your mood, focus, and weight loss.How do you know if you have C. Diff.? Where does it come from? How does it unbalance neurotransmitters in your brain? And how do you get rid of it?We'll be discussing this and more on today's episode. It's time to reveal more about the connection of the gut to the brain!Other episodes mentioned in this episode:Food Sensitivities v. Allergies - Ep. 14// The #1 Lie About Food that I HATEOther links from the show:Schedule Your Qualifying Call with AllisonLeave a Rating and Review because you love us!Connect with us on social media!Facebook: @betterbellytherapiesInstagram: @betterbellytherapiesWebsite: betterbellytherapies.com*This episode was first published at BetterBellyTherapies.com/podcast/41.

adhd diff anxiety depression one reason food sensitivities clostridium difficile

Clostridium Difficile Infection: You Want to Transplant What?!

Mayo Clinic Talks

Play Episode Listen Later Mar 9, 2021 27:07

Guest: Maria I. Vazquez Roque, M.D. (@MVazquezRoqueMD) Host: Darryl S. Chutka, M.D. (@ChutkaMD) Clostridium difficile is a toxin-producing bacterium that can result in a severe form of antibiotic-associated diarrhea known as clostridium difficile infection or CDI. Cases can vary from mild diarrhea to severe colitis that at times can be fatal. There's been a dramatic increase in the number as well as severity of CDIs in the U.S. over the past 20 years. Although CDI typically occurs following the use of antibiotics, it can also be spread from one individual to another, especially in hospitals and skilled nursing facilities. Antibiotics have been the traditional treatment for patients with CDI, however recurrent symptoms have been a problem. There's now a new treatment for CDI, felt to be effective in over 90% of patients with the illness. Our guest to discuss this topic is Dr. Maria Vazquez Roque, a gastroenterologist at the Mayo Clinic. We'll review the common presenting symptoms, laboratory tests needed to establish a diagnosis, and the current recommendations for treatment including the latest of fecal transplantation. Additional resources: Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): https://doi.org/10.1093/cid/cix1085 Specific topics discussed: The typical presentation of C. difficile infection Patients who are at increased risk for a C. difficile infection Laboratory tests to order to confirm a case of C. difficile infection Treatment options for C. difficile infection including fecal transplantation Potential benefit of probiotics for preventing a C. difficile infection Connect with the Mayo Clinic's School of Continuous Professional Development online at https://ce.mayo.edu/ or on Twitter @MayoMedEd.

children school society adults infection transplants mayo clinic antibiotics cdi clostridium infectious diseases society clostridium difficile america idsa healthcare epidemiology cdis continuous professional development america shea

C. DIFF ( Clostridium difficile) is there a Cure?

united states health fitness wellness natural cure functional medicine microbiome probiotics ozone voiceamerica clostridium ozone therapy c diff clostridium difficile

Play Episode Listen Later Mar 4, 2021 60:00

Clostridium difficile A.K.A. C DIFF , is an intestinal infection caused by TAKING antibiotics for other infections, eating foods containing antibiotics or transmission by contact with the bacteria in contaminated settings such as hospitals.500,000 people in the USA get it every year (hundreds of thousands more worldwide) and 30,000 people, mostly seniors and children die each year from the complications of the uncontrolled diarrhea that it causes. We will discuss the latest NATURAL ways to treat it to successfully eliminate, permanently, completely once and for all!

C. DIFF ( Clostridium difficile) is there a Cure?

united states health fitness wellness natural cure functional medicine microbiome probiotics ozone voiceamerica clostridium ozone therapy c diff clostridium difficile

Play Episode Listen Later Mar 4, 2021 60:00

Clostridium difficile A.K.A. C DIFF , is an intestinal infection caused by TAKING antibiotics for other infections, eating foods containing antibiotics or transmission by contact with the bacteria in contaminated settings such as hospitals.500,000 people in the USA get it every year (hundreds of thousands more worldwide) and 30,000 people, mostly seniors and children die each year from the complications of the uncontrolled diarrhea that it causes. We will discuss the latest NATURAL ways to treat it to successfully eliminate, permanently, completely once and for all!

Calculating Clostridium Difficile: Diagnostic & Treatment Standards

GI Insights

Play Episode Listen Later Mar 2, 2021

Host: Peter Buch, MD, FACG, AGAF, FACP Guest: Paul Feuerstadt MD, FACG, AGAF Clostridium difficile impacts many patients around the United States. How can we better diagnose and treat this infection? Dr. Peter Buch is joined by Dr. Paul Feuerstadt, Assistant Clinical Professor of Medicine at Yale New Haven Hospital the discuss the importance of managing Clostridium difficile.

united states medicine md treatments standards surgery diagnostic calculating assistant clinical professor rmd clostridium yale new haven hospital clostridium difficile reachmd general medicine and primary care agaf gastroenterology and hepatology gi insights

"C.diff", Clostridium difficile infection and the new effective way to prevent and treat it.

health americans fitness wellness treat prevent mic infection functional medicine probiotics voiceamerica effective way clostridium ozone therapy c diff clostridium difficile

Play Episode Listen Later Aug 20, 2020 60:00

Clostridium difficile, A.K.A. C. diff, is a bacteria found in your gut. After taking antibiotics the good and bad bacteria in your gut which keeps C. diff in check are destroyed allowing it to overgrow and overwhelm your digestive system. This leads to uncontrolled diarrhea. 500,000 Americans get it every year and 28,000 avg. will die from it, mostly seniors and children.Our show will discuss the latest and newest ways to prevent and treat it and home and in a doctors office using ozone therapy and the latest and best probiotics.

"C.diff", Clostridium difficile infection and the new effective way to prevent and treat it.

health americans fitness wellness treat prevent mic infection functional medicine probiotics voiceamerica effective way clostridium ozone therapy c diff clostridium difficile

Play Episode Listen Later Aug 20, 2020 60:00

Clostridium difficile, A.K.A. C. diff, is a bacteria found in your gut. After taking antibiotics the good and bad bacteria in your gut which keeps C. diff in check are destroyed allowing it to overgrow and overwhelm your digestive system. This leads to uncontrolled diarrhea. 500,000 Americans get it every year and 28,000 avg. will die from it, mostly seniors and children.Our show will discuss the latest and newest ways to prevent and treat it and home and in a doctors office using ozone therapy and the latest and best probiotics.

Clostridium difficile

Bradley's Micro Board Review

Play Episode Listen Later Apr 27, 2020 9:32

Today we'll talk about a diarrhea-causing organism who's smell haunts healthcare workers worldwide. --- Send in a voice message: https://anchor.fm/bradleysmicroboardreview/message Support this podcast: https://anchor.fm/bradleysmicroboardreview/support

clostridium difficile

Encore: CDC Physicians discuss current issues and potential solutions focused on C diff Infections and antibiotic use

The Forum at Harvard T.H. Chan School of Public Health

Play Episode Listen Later Nov 12, 2019 51:10

Join us and learn from our guests; Dr. Clifford McDonald, MD, Senior Advisor for Science and Integrity, Division of Healthcare Quality Promotion at the CDC with main interests in epidemiology and prevention of Healthcare-Associated Infections, especially Clostridium difficile infections, and the prevention of antimicrobial resistance. And Dr. Arjun Srinivasan, MD, Associate Director for Healthcare-Associated Infection prevention programs in the Division of Healthcare Quality Promotion at CDC's National Center for Emerging and Zoonotic Infectious Disease. Listen in as these two stellar Physicians discuss the topics of Clostridium difficile infections and Antibiotic usage, two important issues with potential solutions facing the citizens on a global level..

Drug-Resistant Infections: Confronting an Escalating Crisis

Play Episode Listen Later Oct 25, 2019 58:10

Antibiotics are a pillar of modern medicine. They have saved millions of lives. But as the use of antibiotics has increased, so has the proliferation of antibiotic-resistant microbes that have adapted to survive most, or all, of today's antibiotics. The CDC reports that two million people are infected with drug-resistant bacteria every year in the United States, and the Review on Antimicrobial Resistance estimated that, around the world, 700,000 people die of such infections annually. That number stands to increase: the Review predicts that, by 2050, drug resistance could be responsible for 10 million deaths a year. And while these numbers are dominated by bacterial infections, fungal infections like Candida auris are also a threat, especially to vulnerable patients in hospitals and nursing homes. Despite drug resistance growing, the development of new antibiotics has slowed. How can policymakers help accelerate the pace of new drug development, and how can all of us—doctors, hospitals, and patients, as well as the agricultural sector—be better stewards of existing drugs? Forum panelists examined the scope of this looming crisis and look at how changes in policy and practice can help us stay one step ahead of these superbugs. Watch the entire series: https://theforum.sph.harvard.edu/

united states crisis vaccines cdc drug forum confronting infection hygiene antibiotics resistant escalating mrsa drug development antibiotic resistance antimicrobial resistance drug resistance candida auris clostridium difficile

Clinical Trial Awareness;Treating and Preventing C.diff Infection

health science internet talk phd radio wellness fda treating preventing infection clinicians providers clinical trials voiceamerica c diff clinical studies clostridium difficile c difficile

Play Episode Listen Later Jul 16, 2019 54:51

Join us with guest Sarah Mische, PhD as we discuss the value and importance of Clinical Trials worldwide. Learn about the different phases, the efficacy, patient safety, and research and development that begins the process. Clinical Trials have a beginning, evaluations, FDA meetings, with time well spent by dedicated Science professionals, Clinicians, Health care Providers, and the individuals who are accepted to participate in the studies. It will be an episode you won't want to miss! Listen in and learn how we can help them - to help you - to help others.

Clinical Trial Awareness;Treating and Preventing C.diff Infection

health science internet talk phd radio wellness fda treating preventing infection clinicians providers clinical trials voiceamerica c diff clinical studies clostridium difficile c difficile

Play Episode Listen Later Jul 9, 2019 54:51

Join us with guest Sarah Mische, PhD as we discuss the value and importance of Clinical Trials worldwide. Learn about the different phases, the efficacy, patient safety, and research and development that begins the process. Clinical Trials have a beginning, evaluations, FDA meetings, with time well spent by dedicated Science professionals, Clinicians, Health care Providers, and the individuals who are accepted to participate in the studies. It will be an episode you won't want to miss! Listen in and learn how we can help them - to help you - to help others.

Encore: C.difficile Diagnosis

Play Episode Listen Later Jun 18, 2019 55:33

Join us with guests Dr. David Lyerly, PhD , PhD - Co-Founder, CSO of TechLab and James H. Boone, M.S.,Director of Collaborative Studies, Senior Research Scientist at TechLab. Both guests will be discussing C.diff. (C.difficile) research,clinical assays for enteric and autoimmune diseases including inflammatory bowel diseases, CDI Guidelines. Dr. Lyerly, PhD and James H. Boone will also be discussing the symptoms and lab testing focused on a C. difficile infection. If you have specific questions to be shared with our guests during the show - please e-mail them ahead of time to info@cdifffoundation.org Thank you.

director health internet talk phd radio wellness hospitals diagnosis infection cso diagnostics voiceamerica senior research scientist c diff clostridium difficile c difficile collaborative studies

C.difficile Diagnosis

Play Episode Listen Later Mar 19, 2019 55:33

Join us with guests Dr. David Lylerly, PhD - Co-Founder, CSO of TechLab and James H. Boone, M.S.,Director of Collaborative Studies, Senior Research Scientist at TechLab. Both guests will be discussing C.diff. (C.difficile) research,clinical assays for enteric and autoimmune diseases including inflammatory bowel diseases, CDI Guidelines. Dr. Lylerly and James H. Boone will also be discussing the symptoms and lab testing focused on a C. difficile infection. If you have specific questions to be shared with our guests during the show - please e-mail them ahead of time to info@cdifffoundation.org Thank you.

director health internet talk radio wellness hospitals diagnosis infection cso diagnostics voiceamerica senior research scientist c diff clostridium difficile c difficile collaborative studies

A Novel Approach to C.diff. Infections

health internet talk ms radio wellness hospitals rn infection pharmaceutical voiceamerica c diff clostridium difficile c difficile

Play Episode Listen Later Mar 12, 2019 52:39

Guest Host: Kevin Hersh and guests Susan Maboe Johnston, RN BS and Diana Gallagher, MS, RN, CWOCN CFCN will be discussing the risks that lead to infection in the hospital, and other healthcare settings, including the challenges of skin decontamination in the hospital or acute care setting.

Clinical Trial Awareness;Treating and Preventing C.diff Infection

health science internet talk phd radio wellness fda treating preventing infection clinicians providers clinical trials voiceamerica c diff clinical studies clostridium difficile c difficile

Play Episode Listen Later Jan 22, 2019 56:55

Join us with guest Sarah Mische, PhD as we discuss the value and importance of Clinical Trials worldwide. Learn about the different phases, the efficacy, patient safety, and research and development that begins the process. Clinical Trials have a beginning, evaluations, FDA meetings, with time well spent by dedicated Science professionals, Clinicians, Health care Providers, and the individuals who are accepted to participate in the studies. It will be an episode you won't want to miss! Listen in and learn how we can help them - to help you - to help others.

Managing C. difficile infection at the point of discharge

health internet talk radio managing wellness hospitals infection pharmaceutical discharge cdi voiceamerica c diff clostridium difficile c difficile

Play Episode Listen Later Jan 15, 2019 53:29

Join us as Brandon and Nicole Bookstaver discuss Managing Clostridium difficile infection at the point of discharge - We will be discussing transitions of care, importance of adherence and we'll touch on strategies of prevention and prophylaxis for patients who have already had a case of CDI (aka secondary prevention).

Rebiotix: Patients, Clinical Trials and Drug Development

Play Episode Listen Later Dec 18, 2018 50:42

Join us with guests Ken Blount, Ph.D., Chief Scientific Officer and Paul Plumb, Head of Clinical Operations from Rebiotix. Ken and Paul will discuss the gut microbiome and the role it plays in overall health and Rebiotix's goal to rehabilitate the gut microbiome by utilizing their unique Microbiota Restoration Therapy™ (MRT) Platform through its extensive clinical trial program. The science behind their products, product development and how patients are an important part of helping develop new drugs will also be discussed.

head health internet talk radio wellness patients microbiome clinical trials chief scientific officer voiceamerica drug development clinical operations c diff clostridium difficile rebiotix

Encore: Clinical Trial Awareness;Treating and Preventing C.diff Infection